Jofe M H, Gebhardt M C, Tomford W W, Mankin H J
Orthopaedic Oncology Unit, Massachusetts General Hospital, Boston 02114.
J Bone Joint Surg Am. 1988 Apr;70(4):507-16.
One of the most difficult problems in orthopaedic oncology is reconstruction after resection of a tumor of the proximal end of the femur. In order to achieve a wide margin about a primary or secondary malignant neoplasm of bone, it is often necessary to resect not only the hip joint and fifteen or more centimeters of the proximal part of the femur, but also the surrounding envelope of soft tissue. In some patients, little is left but the sciatic and femoral nerves and vessels. Since 1971, we have done reconstructions in forty-four patients, using an allograft and an implant or else an osteoarticular graft alone to replace the proximal end of the femur. Twenty-eight of these reconstructions were performed in patients who had had a malignant tumor and were followed for two to fifteen years postoperatively. Fifteen of the patients had only an osteoarticular graft, and thirteen had an allograft and a prosthesis (nine Austin Moore, two bipolar, and two long-stem total hip replacements). The average length of the femoral segment was 18.4 centimeters; the longest one measured thirty-one centimeters. Using an evaluation system of functional end-results that includes failures as a result of recurrence of the tumor, we recorded approximately 70 per cent excellent and good results for both groups. When the two failures that were due to recurrence of the tumor were omitted from the statistics (in order to evaluate the allograft procedure more fully), the successful results increased to about 80 per cent. In general, the patients who had an osteoarticular reconstruction fared less well than did those who had an allograft and a prosthesis, but the series were not quite comparable. The major complications were metastases in nine patients (five of whom died), infection in five, and fracture of the allograft in six. Restoration of the reconstruction was possible for most of the patients who had a problem that was not related to the tumor, and only one patient required an amputation for recurrent tumor. Despite the many difficulties, we think that an allograft, with or without a prosthetic implant, should be given primary consideration as a means of reconstruction of the limb when resection of a tumor necessitates resection of a long segment of the proximal end of the femur.
骨科肿瘤学中最棘手的问题之一是股骨近端肿瘤切除后的重建。为了在原发性或继发性骨恶性肿瘤周围获得足够的切缘,往往不仅需要切除髋关节以及股骨近端15厘米或更长的部分,还需切除周围的软组织包膜。在一些患者身上,除了坐骨神经、股神经和血管外,几乎没有什么留存。自1971年以来,我们已为44例患者进行了重建手术,采用同种异体骨和植入物,或者仅使用骨关节移植来替代股骨近端。其中28例重建手术是针对患有恶性肿瘤的患者,术后随访了2至15年。15例患者仅接受了骨关节移植,13例患者接受了同种异体骨和假体(9例奥斯汀·摩尔假体、2例双极假体和2例长柄全髋关节置换)。股骨段的平均长度为18.4厘米;最长的一段为31厘米。使用包括因肿瘤复发导致的失败情况在内的功能最终结果评估系统,我们记录到两组的优良率约为70%。若将因肿瘤复发导致的2例失败情况排除在统计之外(以便更全面地评估同种异体骨手术),成功结果升至约80%。总体而言,接受骨关节重建的患者情况不如接受同种异体骨和假体的患者,但两组情况不太具有可比性。主要并发症包括9例患者发生转移(其中5例死亡)、5例感染以及6例同种异体骨骨折。对于大多数出现与肿瘤无关问题的患者,重建修复是可行的,只有1例患者因肿瘤复发需要截肢。尽管存在诸多困难,但我们认为,当肿瘤切除需要切除股骨近端的长段时,无论有无假体植入,同种异体骨都应作为肢体重建的首选方法。